Literature DB >> 31264105

Left ventricular epicardial lead placement after Carillon placement in the coronary sinus.

C A da Fonseca1, F S van den Brink2, M Feenema2, K Kraaier2, T N Vossenberg2.   

Abstract

Entities:  

Year:  2019        PMID: 31264105      PMCID: PMC6773791          DOI: 10.1007/s12471-019-1298-2

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


× No keyword cloud information.
A 72-year-old man with ischaemic cardiomyopathy and secondary mitral regurgitation developed heart failure. Due to the absence of options for revascularisation that would improve left ventricular function, poor functional status and a high Euro-SCORE II, the patient was deemed unfit for surgery. Furthermore, a cleft mitral valve also made him unsuitable for MitraClip [1]. To reduce mitral regurgitation he received treatment with a Carillon device for mitral valve annuloplasty in the coronary sinus (Fig. 1; [2]). Unfortunately, this did not reduce MR. In time he developed a left bundle branch block which made him eligible for placement of a cardiac resynchronisation therapy defibrillator (CRT-D) [3].
Fig. 1

a The Carillon device (1) with the right atrial (2) and right ventricular (3) leads; b the Carillon device (1) and the left ventricular epicardial lead (4) in the coronary sinus. This illustrates the possibility of placing a Carillon device and a left ventricular lead in the coronary sinus in the treatment of mitral regurgitation and heart failure

a The Carillon device (1) with the right atrial (2) and right ventricular (3) leads; b the Carillon device (1) and the left ventricular epicardial lead (4) in the coronary sinus. This illustrates the possibility of placing a Carillon device and a left ventricular lead in the coronary sinus in the treatment of mitral regurgitation and heart failure There were no complications and the patient’s functional status improved significantly.
  3 in total

Review 1.  Echocardiographic evaluation and guidance for MitraClip procedure.

Authors:  William E Katz; Anson J Conrad Smith; Frederick W Crock; João L Cavalcante
Journal:  Cardiovasc Diagn Ther       Date:  2017-12

2.  Cardiac resynchronisation therapy after percutaneous trans-coronary-venous mitral annuloplasty.

Authors:  Tomasz Siminiak; Olga Jerzykowska; Piotr Kalmucki; Rafał Link; Artur Baszko
Journal:  Kardiol Pol       Date:  2013       Impact factor: 3.108

3.  Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.

Authors:  Tomasz Siminiak; Justina C Wu; Michael Haude; Uta C Hoppe; Jerzy Sadowski; Janusz Lipiecki; Jean Fajadet; Amil M Shah; Ted Feldman; David M Kaye; Steven L Goldberg; Wayne C Levy; Scott D Solomon; David G Reuter
Journal:  Eur J Heart Fail       Date:  2012-05-21       Impact factor: 15.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.